Cresco Labs Inc.
corporate_fare Company Profile
Cresco Labs Inc. (OTC:CRLBF) is a publicly traded company in the Life Sciences sector. Wiseek monitors CRLBF SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Cresco Labs Reports Q1 Loss Amid Revenue Decline; Highlights Transformative Cannabis Rescheduling & Strategic Expansion
- Medical Cannabis Rescheduling to Schedule III Powers Cresco Labs' Q1 Growth
- Cresco Labs Posts $162M Q4 Revenue, Boosts Margins Sequentially
- Cresco Labs Establishes US$100M At-the-Market Offering for Capital Needs
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for CRLBF, detected from its recent SEC filings · based on capital-structure filings through 2026-01-30.
Establishes C$140M (US$100M) At-the-Market Offering · Significant Potential Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
CRLBF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.